On October 1, 2026, a publication titled "Terlipressin in paediatric hepatorenal syndrome-acute kidney injury (HRS-AKI)" appeared in the journal Pediatric Nephrology. The publication is listed under PubMed ID 41711944. This entry concerns terlipressin, a compound related to lypressin, in the context of hepatorenal syndrome-acute kidney injury in pediatric patients. No findings, outcomes, or conclusions from the publication are included in this brief. The publication record does not specify study design, phase, or results within the data provided. Lypressin itself remains classified as unapproved and intended for research use only. This brief reports only the existence and bibliographic details of the publication as recorded. Readers interested in further detail should consult the original journal article directly through the listed source. For broader context on lypressin, including its classification and research status, see the compound overview.
Publication on Terlipressin in Pediatric HRS-AKI Released
See the full lypressin overview
Source: https://pubmed.ncbi.nlm.nih.gov/41711944/